Treatment of cognitive impairment in arterial hypertension

Nevrologiâ, Nejropsihiatriâ, Psihosomatika

Yu. A. Starchina¹  K. S. Sleptcova¹ 

[1] I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia;

关键词: arterial hypertension;    cognitive impairment;    dementia;    antihypertensive therapy;    stroke;    microangiopathy;    memantine;   

DOI  :  10.14412/2074-2711-2021-5-90-95

来源: DOAJ

【 摘 要 】

Cognitive impairment (CI) is one of the earliest and most frequent neurological disorders in patients with arterial hypertension. Arterial hypertension is a leading modifiable risk factor for stroke and cerebral microangiopathy, which underlies the development of non-stroke associated CI. Antihypertensive therapy plays an essential role in preventing the development and slowing the progression of CI by controlling blood pressure. The review discusses the use of memantine – a reversible inhibitor of NMDA receptors (akatinol memantine) – in vascular CI.

【 授权许可】

Unknown